Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
The epidemiology and clinical features of portal vein thrombosis: a multicentre study
2010
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics
2013 StandoutNobel
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome
2006
Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome
2004
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
Long-term portosystemic shunt patency as a determinant of outcome in Budd–Chiari syndrome
2006
Perioperative Management of Antithrombotic Therapy
2012 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Alcoholic liver disease: mechanisms of injury and targeted treatment
2015
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Gastric and Ectopic Varices
2014
Vasoactive substances in the circulatory dysfunction of cirrhosis
2001
Prevention of VTE in Nonsurgical Patients
2012 Standout
Vascular disorders of the liver # †
2008 Standout
Acute Mesenteric Ischemia
2004 Standout
Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity
2006 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Oxidative stress and redox signaling mechanisms of alcoholic liver disease: Updated experimental and clinical evidence
2011
Portal hypertensive bleeding in cirrhosis
2016 Standout
Executive Summary
2012 Standout
Cirrhotic cardiomyopathy: pathogenesis and clinical relevance
2013
Hypercoagulability in cirrhosis: causes and consequences
2011
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
AGA technical review on intestinal ischemia
2000 Standout
Pulmonary–Hepatic vascular Disorders (PHD)
2004
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Mesenteric Venous Thrombosis
2013
Thrombophilic dimension of Budd chiari syndrome and portal venous thrombosis – A concise review
2010
High brain-natriuretic peptide level predicts cirrhotic cardiomyopathy in liver transplant patients
2011
Anemia and ischemia: Myocardial injury in patients with gastrointestinal bleeding
2005
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease
2002
PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome
2004
Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event
2014 StandoutNobel
Pulmonary Arterial Hypertension in France
2006 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease
2018
Etiology, Management, and Outcome of the Budd-Chiari Syndrome
2009
Survival at 2 years among liver cirrhotic patients is influenced by left atrial volume and left ventricular mass
2016
Cardiac and proinflammatory markers predict prognosis in cirrhosis
2013
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
The Role of Oxidative Stress and Antioxidants in Liver Diseases
2015 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
2013 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Works of Philippe Langlet being referenced
Acute Portal Vein Thrombosis Unrelated to Cirrhosis: A Prospective Multicenter Follow-Up Study
2009
Elevated Circulating Cardiac Troponin I in Patients With Cirrhosis
1999
Evolution of hypoxemia in patients with severe cirrhosis
2002
Clinicopathological forms and prognostic index in Budd-Chiari syndrome
2003
Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: A randomized multicenter controlled trial
2010
Elevated circulating cardiac troponin I in patients with cirrhosis
1999
Impaired fibrinolysis as a risk factor for Budd-Chiari syndrome
2009